π RIP WAR ON CANCER 1971-2025 π
Trumpβs hit job on cancer research grants reads like satire, except patients paid the price.
The New York Times showed how his administration froze or axed studies because they dared to mention equity, LGBTQ health, or racial disparities. Courts already ruled some of these cuts illegal. That means discrimination wasnβt a side effect. It was the policy.
Cancer research lives and dies on NIH grants. A single award funds years of lab work, salaries, and trial prep. Pull that midstream and you donβt βsave money.β You destroy careers, dismantle labs, and strand patients waiting on clinical trials. Once you scatter a team, the science is gone. You canβt reassemble a decade of work like Lego bricks.
NIH anchors global cancer research. When ideology hijacks that pipeline, the fallout isnβt abstract. Fewer therapies, more disparities, and an exodus of talent. Americaβs reputation as the worldβs leader in biomedical science gets auctioned off to score cheap political points.
Patients get collateral damage while politicians pose for cameras.
The cruelty is blatant. Cancer doesnβt care if your grant mentions βequity.β Yet politicians shredded entire programs over buzzwords. Thatβs not governance. Thatβs vandalism dressed up as oversight. Every cut landed on real people, not line items.
Imagine if patients organized the way industries do. Why is there no cancer lobby. Suppose the day comes when patients stop begging for scraps and act like a constituency.
If this hits home, toss it a like, a repost, comment, or tag someone you may be ambivalent about. One click makes a bigger difference than you think.
SOURCE β‘οΈ https://www.nytimes.com/2025/09/14/magazine/cancer-research-grants-funds-trump.html?unlocked_article_code=1.mE8.W_KQ.9c4XJXhVYANG&smid=url-share
